April 8 (Reuters) - AbbVie (ABBV.N), opens new tab has filed a lawsuit against the U.S. government, seeking clearer guidance on patients eligible for a drug discount program. Under ‌the 340B program, ...

JPMorgan maintains its Overweight rating and $260 price target on AbbVie (ABBV), calling the pullback a buying opportunity as the firm sees upside to consensus estimates backed by strong Skyrizi and ...

Two more drug-making giants will officially start selling popular commercial medications on the White House's discounted pharmaceutical site as soon as Monday, CBS News exclusively learned. American ...

AbbVie (ABBV) and Roche’s (RHHBY) Genentech unit have become the latest drugmakers to offer their medicines on TrumpRx, a government-run direct-to-consumer platform launched earlier this year, ...

AbbVie's growth rate has been impressive given the headwinds it has faced. This year, it's forecasting a significant increase in its earnings. AbbVie has faced some significant challenges in recent ...

Shares of AbbVie Inc. ABBV rose 2.05% to $217.49 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index SPX rising 2.91% to 6,528.52 and the ...

Johnson & Johnson’s immunology drug Tremfya is looking to challenge AbbVie’s dominance in 2026, securing the top spot as the biggest TV drug ad spender in March. J&J spent $50.3 million on TV ads for ...

AbbVie (ABBV) has issued a preliminary financial update, lowering its earnings expectations for the first quarter and full year of 2026. The revision stems from $744 million in pre-tax expenses ...

Media enquiries: Elizabeth Tang, Pipeline and External Innovation Communications, AbbVie, [email protected]. AbbVie Ventures: ventures.abbvie.com, [email protected] AbbVie’s leadership in major, ...

Installing Samsung Browser on a Windows PC is simple and takes just a few steps. It is compatible with Windows 11 and Windows 10. You’ll be prompted to sign in with your Samsung account. Signing in ...